- PURPOSE
- Drug Facts
- Uses
-
Warnings
- Abdominal cramps, nausea, vomiting, diarrhea, headache or dizziness sometimes occur after taking this drug. If any of these conditions persist, consult a physician.
- Keep this and all medications out of reach of children.
- In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
- Do not use
- When using this product
-
Directions
- Adults and children 2 years to 12 years of age may take this product. Take the dosage in Table I according to the body weight of the individual treated. Do not exceed 4 teaspoonful (20.0 mL) of Pyrantel Pamoate Oral Suspension.
- Carefully read additional product information (located on the inside of label) before using this medication. Take only according to directions and do not exceed the recommended dosage unless directed by a physician. Medication should only be taken one time as a single dose, do not repeat treatment unless directed by a physician. When one individual in a household has pinworms, the entire household should be treated unless otherwise advised. See WARNINGS. If any worms other than pinworms are present before or after treatment, consult a physician. If any symptoms or pinworms are still present after treatment, consult a physician.
- This product can be taken any time of day, with or without meals. It may be taken alone or with milk or juice. Use of a laxative is not necessary prior to, during or after medication.
- Dosage Information
-
Table 1.Pyrantel Pamoate Oral Suspension Dosage Guide
Less than 25 lbs.
(11 Kg) or under 2 years old
Do not use unless
directed by a physician
25-37 lbs. (11-16 kg) 1/2 teaspoonful (2.5 mL) 38-62 lbs. (17-28 kg) 1 teaspoonful (5.0 mL) 63-87 lbs. (29-39 kg) 1 1/2 teaspoonful (7.5 mL) 88-112 lbs. (40-50 kg) 2 teaspoonful (10.0 mL) 113-137 lbs. (51-62 kg) 2 1/2 teaspoonful (12.5 mL) 138-162 lbs. (63-73 kg) 3 teaspoonful (15.0 mL) 163-187 lbs. (74-84 kg) 3 1/2 teaspoonful (17.5 mL) 188 lbs. (85 kg and over) 4 teaspoonful (20.0 mL) - Other Information
- STORAGE AND HANDLING
- Inactive Ingredients
- QUESTIONS
- SPL UNCLASSIFIED SECTION
- KEEP OUT OF REACH OF CHILDREN
- PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label
-
INGREDIENTS AND APPEARANCE
PYRANTEL PAMOATE
pyrantel pamoate suspensionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:51072-088 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PYRANTEL PAMOATE (UNII: 81BK194Z5M) (PYRANTEL - UNII:4QIH0N49E7) PYRANTEL 50 mg in 1 mL Inactive Ingredients Ingredient Name Strength CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) POTASSIUM SORBATE (UNII: 1VPU26JZZ4) GLYCERIN (UNII: PDC6A3C0OX) SODIUM BENZOATE (UNII: OJ245FE5EU) SUCRALOSE (UNII: 96K6UQ3ZD4) XANTHAN GUM (UNII: TTV12P4NEE) WATER (UNII: 059QF0KO0R) Product Characteristics Color white Score Shape Size Flavor VANILLA (custard) Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:51072-088-00 946 mL in 1 BOTTLE; Type 0: Not a Combination Product 11/21/2015 2 NDC:51072-088-01 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 12/28/2017 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part357B 11/21/2015 Labeler - Jefferson Labs (832848639) Establishment Name Address ID/FEI Business Operations Jefferson Labs 832848639 manufacture(51072-088)